CA2027930A1 - Complexes polymeriques se comportant comme des sucres - Google Patents

Complexes polymeriques se comportant comme des sucres

Info

Publication number
CA2027930A1
CA2027930A1 CA2027930A CA2027930A CA2027930A1 CA 2027930 A1 CA2027930 A1 CA 2027930A1 CA 2027930 A CA2027930 A CA 2027930A CA 2027930 A CA2027930 A CA 2027930A CA 2027930 A1 CA2027930 A1 CA 2027930A1
Authority
CA
Canada
Prior art keywords
response type
boronic acid
polymer
polymer complexes
sugar response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2027930A
Other languages
English (en)
Other versions
CA2027930C (fr
Inventor
Tsuyoshi Miyazaki
Yoshishige Murata
Daijiro Shiino
Kazunori Waki
Yasuhisa Sakurai
Teruo Okano
Kazunori Kataoka
Yoshiyuki Koyama
Masayuki Yokoyama
Shigeru Kitano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2241191A external-priority patent/JP2874309B2/ja
Priority claimed from JP02241192A external-priority patent/JP3087293B2/ja
Application filed by Individual filed Critical Individual
Publication of CA2027930A1 publication Critical patent/CA2027930A1/fr
Application granted granted Critical
Publication of CA2027930C publication Critical patent/CA2027930C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002027930A 1989-10-19 1990-10-18 Complexes polymeriques se comportant comme des sucres Expired - Fee Related CA2027930C (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP1-270215 1989-10-19
JP27021589 1989-10-19
JP2241191A JP2874309B2 (ja) 1990-09-13 1990-09-13 糖応答性高分子複合体
JP02241192A JP3087293B2 (ja) 1990-09-13 1990-09-13 糖応答型高分子複合体
JP2-241191 1990-09-13
JP2-241192 1990-09-13

Publications (2)

Publication Number Publication Date
CA2027930A1 true CA2027930A1 (fr) 1991-04-20
CA2027930C CA2027930C (fr) 1998-06-30

Family

ID=27332917

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002027930A Expired - Fee Related CA2027930C (fr) 1989-10-19 1990-10-18 Complexes polymeriques se comportant comme des sucres

Country Status (8)

Country Link
US (1) US5478575A (fr)
EP (1) EP0424168B1 (fr)
KR (1) KR930001305B1 (fr)
AU (1) AU628674B2 (fr)
CA (1) CA2027930C (fr)
DE (1) DE69003068T2 (fr)
DK (1) DK0424168T3 (fr)
TW (1) TW218353B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2251008C (fr) * 1996-04-05 2007-11-13 The Board Of Trustees Of The University Of Illinois Complexes macromoleculaires pour administration de medicaments
US5935599A (en) * 1996-10-28 1999-08-10 The Board Of Trustees Of The University Of Illinois Polymer-associated liposomes for drug delivery and method of manufacturing the same
US7316999B2 (en) * 2000-06-02 2008-01-08 Novo Nordisk A/S Glucose dependent release of insulin from glucose sensing insulin derivatives
JP2003535106A (ja) * 2000-06-02 2003-11-25 ノボ ノルディスク アクティーゼルスカブ グルコース検知性インスリン誘導体からの、インスリンのグルコース依存性放出
US6417237B1 (en) 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
KR100431536B1 (ko) * 2001-02-14 2004-05-20 박상규 ｐＨ변화를 이용한 식품 품질 식별표시계
EP1391209A4 (fr) * 2001-05-30 2009-12-16 Chugai Pharmaceutical Co Ltd Formulations de proteines
US7317000B2 (en) 2001-12-02 2008-01-08 Novo Nordisk A/S Glucose-dependent insulins
EP1453860A2 (fr) * 2001-12-02 2004-09-08 Novo Nordisk A/S Nouvelles insulines gluco-dependantes
GB0305587D0 (en) * 2003-03-11 2003-04-16 Smart Holograms Ltd Sensor
CA2575431A1 (fr) * 2004-07-30 2006-02-02 Basf Ag Derives d'acide boronique polymeriques et utilisation dans la fabrication du papier
CA2507121A1 (fr) * 2005-05-12 2006-11-12 Le Groupe Lysac Inc. Complexes de galactomannan hydrophobes utilises comme polymeres superabsorbants
GB0519169D0 (en) * 2005-09-21 2005-10-26 Leuven K U Res & Dev Novel anti-viral strategy
ES2553154T3 (es) * 2006-05-09 2015-12-04 Novo Nordisk A/S Derivado de la insulina
CN101573133B (zh) * 2006-07-31 2014-08-27 诺沃-诺迪斯克有限公司 Peg化延长的胰岛素
EP2404934A1 (fr) * 2006-09-22 2012-01-11 Novo Nordisk A/S Analogues d'insuline résistants à la protéase
WO2008132224A2 (fr) * 2007-04-30 2008-11-06 Novo Nordisk A/S Procédé de déshydratation d'une composition de protéine, composition de protéine déshydratée et composition pharmaceutique contenant la protéine déshydratée
JP5675347B2 (ja) * 2007-06-01 2015-02-25 ノボ・ノルデイスク・エー／エス 安定した非水性薬学的組成物
WO2009112583A2 (fr) * 2008-03-14 2009-09-17 Novo Nordisk A/S Analogues de l’insuline stabilisés une protéase
AU2009226910B2 (en) 2008-03-18 2014-02-06 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
CN105753965A (zh) 2009-01-28 2016-07-13 斯马特塞尔斯公司 用于受控药物递送的基于缀合物的系统
BRPI1007466A2 (pt) 2009-01-28 2018-06-12 Smartcells Inc conjugado de insulina cristalina, formulação de liberação prolongada, e, sistema de distribuição de bomba
WO2010088268A1 (fr) 2009-01-28 2010-08-05 Smartcells, Inc. Matériaux à libération contrôlée déclenchée de façon exogène et leurs utilisations
JP2012516340A (ja) 2009-01-28 2012-07-19 スマートセルズ・インコーポレイテツド 合成コンジュゲートおよびその使用
US8569231B2 (en) 2009-03-20 2013-10-29 Smartcells, Inc. Soluble non-depot insulin conjugates and uses thereof
EP2408808A4 (fr) 2009-03-20 2015-05-06 Smartcells Inc Conjugués fonctionnalisés aux extrémités et leurs utilisations
WO2011000823A1 (fr) 2009-06-30 2011-01-06 Novo Nordisk A/S Dérivés de l'insuline
EP2582741B1 (fr) 2010-06-18 2016-07-27 Universiteit Twente Polymères borés
AU2011282988A1 (en) 2010-07-28 2013-01-31 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
CA2805739A1 (fr) 2010-07-28 2012-02-02 Smartcells, Inc. Conjugues medicaments-ligands, leur synthese et intermediaires correspondants
AU2011282987A1 (en) 2010-07-28 2013-02-21 Smartcells, Inc. Recombinant lectins, binding-site modified lectins and uses thereof
AU2013247047A1 (en) 2012-04-11 2014-10-23 Novo Nordisk A/S Insulin formulations
WO2013168136A1 (fr) * 2012-05-11 2013-11-14 Schlumberger Technology B.V. Épaississement de fluides
JP6364067B2 (ja) 2013-04-05 2018-07-25 ノボ・ノルデイスク・エー／エス 薬剤送達装置の投与記録装置
KR20160065930A (ko) 2013-10-04 2016-06-09 머크 샤프 앤드 돔 코포레이션 글루코스-반응성 인슐린 접합체
JP6499184B2 (ja) 2013-10-07 2019-04-10 ノヴォ ノルディスク アー／エス インスリン類似体の新規な誘導体
CN105153347B (zh) * 2015-08-11 2017-07-07 台州学院 糖响应的单分散聚合物空心微球的制备方法
JP6937303B2 (ja) * 2015-12-22 2021-09-22 ローム アンド ハース カンパニーＲｏｈｍ Ａｎｄ Ｈａａｓ Ｃｏｍｐａｎｙ 水性媒質中に分布した液滴の懸濁重合の方法
BR112019011761A2 (pt) 2016-12-16 2019-11-05 Novo Nordisk As composições farmacêuticas contendo insulina
US11096893B2 (en) 2017-06-02 2021-08-24 North Carolina State University Glucose sensitive compositions for drug delivery
CN107556509B (zh) * 2017-08-28 2020-07-14 上海第二工业大学 一种二维光子晶体葡萄糖传感薄膜的制备方法
MA50552A (fr) 2017-11-09 2020-09-16 Novo Nordisk As Dérivés de liaison à l'albumine sensibles au glucose
CN108102004B (zh) * 2018-01-03 2020-02-14 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 一种葡聚糖聚合物、聚合物胶束和药物载体系统
CN110452390B (zh) * 2018-05-03 2021-04-06 清华大学深圳研究生院 一种胰岛素智能给药制剂
EP3586876A1 (fr) 2018-06-21 2020-01-01 Gubra ApS Hormones peptidiques sensibles au glucose
TW202112397A (zh) * 2019-03-29 2021-04-01 丹麥商諾佛．儂迪克股份有限公司 葡萄糖敏感型胰島素衍生物
CN110483691B (zh) * 2019-09-25 2021-11-09 安徽大学 一种三元共聚物交联剂及其在扩散渗析专用阳离子膜制备中的应用
CN115975224B (zh) * 2023-03-16 2023-08-08 四川大学 一种pH/ROS双响应的组织粘附载药水凝胶及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983004255A1 (fr) * 1982-05-26 1983-12-08 The Children's Hospital Medical Center Composes informateurs
IT1173459B (it) * 1984-03-22 1987-06-24 Sirac Spa Resine boroniche stabili ad elevato potere assorbente selettivo
IT1215406B (it) * 1987-04-03 1990-02-08 Sirac Spa Resine boroniche stabili di elevato poytere assorbente selettivo.
IT1215407B (it) * 1987-04-03 1990-02-08 Sirac Spa Resine boroniche di elevato potere assorbente selettivo.

Also Published As

Publication number Publication date
AU6475490A (en) 1991-07-11
US5478575A (en) 1995-12-26
DE69003068D1 (de) 1993-10-07
KR930001305B1 (ko) 1993-02-25
KR910007545A (ko) 1991-05-30
DE69003068T2 (de) 1993-12-16
EP0424168A1 (fr) 1991-04-24
TW218353B (fr) 1994-01-01
EP0424168B1 (fr) 1993-09-01
CA2027930C (fr) 1998-06-30
DK0424168T3 (da) 1993-12-13
AU628674B2 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
CA2027930A1 (fr) Complexes polymeriques se comportant comme des sucres
AU640927B2 (en) Water soluble high molecular polymerized drug preparation
CA2071510A1 (fr) Oligonucleotides modifies en 2'
AU632539B2 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
IE893712L (en) Quinuclidines, their use as medicaments and processes for¹their preparation
EP0310361A3 (fr) Conjugat tridenté et méthode de sa mise en oeuvre
EP0355307A3 (fr) Moyens d'extraction de l'acide poly-D(-)-3-hydroxy butyrique
CA2046830A1 (fr) Systeme d'administration des medicaments comprenant une interaction entre une proteine ou une polypeptide et un polymere hydrophobe biodegradable
CA2054752A1 (fr) Composition pharmaceutique comprenant de la loratadine, de l'ibuprofene et de la pseudoephedrine
AU5330390A (en) G-tab manufacturing process and the product produced thereby
IE801932L (en) Copolyesters
CA2150251A1 (fr) Lyospheres contenant de la gonadotropine
EP0674528A4 (fr) Cyclodextrine et systeme de liberation de medicament a base de polymere.
FI906024A (fi) Foerfarande foer att minska uppbyggnad av polymer i vaermevaexlare under polymerisation av alfa-olefiner.
CA2251008A1 (fr) Complexes macromoleculaires pour administration de medicaments
AU6327290A (en) Conjugate fibers and formed product using the same
CA2127636A1 (fr) Plastifiants pour fibres utilises pour former des instruments chirurgicaux
AU1064988A (en) Polymer complexes of metals useful as pharmaceutical agents
AU643679B2 (en) Solid gel external drug delivery system
CA2162154A1 (fr) Utilisation d'un complexe de metal de transition pour le traitement du choc septique
CA2097044A1 (fr) Acides a groupement cyclopentane- et pentene-.beta.-amino
AU5260990A (en) Roboting drug dispensing system
AU5945190A (en) Polymer supported cosmetic products and methods
AU7302091A (en) Polymerization process and the polymers thereof
CA2133955A1 (fr) Hydrogels de polyetheramidoamine utilises comme materiaux heparinisables

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed